Central Clinical Hospital #2 N.A. Semashko OAO RJHD

Moskva, Moscow Oblast 107150

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Multiple Sclerosis, Relapsing-Remitting, Relapsing Multiple Sclerosis

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early